Diablo Clinical Research, Inc | Walnut Creek, CO
Status and phase
Conditions
Treatments
About
The purpose of this study is to learn if modified RNA (modRNA) vaccines for the prevention of influenza are:
RNA (also called ribonucleic acid) is one of two types of nucleic acid made by cells. RNA contains information that has been copied from DNA (the other type of nucleic acid). Cells make several different forms of RNA, and each form has a specific job in the cell. Many forms of RNA have functions related to making proteins. RNA is also the genetic material of some viruses instead of DNA. RNA can be made in the laboratory and used in research studies. Also called ribonucleic acid.
Influenza is term used for flu illness. It is an infection caused by a virus that affects your mouth, nose, and throat.
The study is seeking for participants who:
This study will be divided into three sub-studies: Substudy A (SSA), Substudy B (SSB), and Substudy C (SSC).
All participants, regardless of sub-study, will receive 1 dose of either of the following vaccines as an injection into their arm:
Participants will be involved in this study for about 6 months. During this time, participants will have at least 3 clinic visits.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria
Applies to all 3 substudies:
Substudy C ONLY:
Key Exclusion Criteria
All 3 substudies:
Primary purpose
Allocation
Interventional model
Masking
1,202 participants in 19 patient groups
Loading...
Central trial contact
Pfizer CT.gov Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal